Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2017, Article ID 3835851, 9 pages
https://doi.org/10.1155/2017/3835851
Research Article

Antioxidant and Anti-Inflammatory Activities in Extracts from Minke Whale (Balaenoptera acutorostrata) Blubber

1Norwegian College of Fishery Science, Faculty of Biosciences, Fisheries and Economics, UiT-The Arctic University of Norway, 9037 Tromsø, Norway
2Nofima, Muninbakken 9-13, Pb 6122, 9291 Tromsø, Norway
3Faculty of Health Sciences, IMB, K.G. Jebsen TREC, UiT-The Arctic University of Norway, 9037 Tromsø, Norway

Correspondence should be addressed to Mari Johannessen Walquist; on.tiu@tsiuqlaw.iram

Received 19 May 2017; Revised 28 August 2017; Accepted 17 September 2017; Published 8 October 2017

Academic Editor: Anshu Agrawal

Copyright © 2017 Mari Johannessen Walquist et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. Libby, P. M. Ridker, and G. K. Hansson, “Progress and challenges in translating the biology of atherosclerosis,” Nature, vol. 473, pp. 317–325, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. WHO, Global Status Report on Noncommunicable Diseases 2014, WHO press, Switzerland, 2014.
  3. R. Khan, V. Spagnoli, J.-C. Tardif, and P. L. L'Allier, “Novel anti-inflammatory therapies for the treatment of atherosclerosis,” Atherosclerosis, vol. 240, pp. 497–509, 2015. View at Publisher · View at Google Scholar · View at Scopus
  4. I. Tabas, G. García-Cardeña, and G. K. Owens, “Recent insights into the cellular biology of atherosclerosis,” The Journal of Cell Biology, vol. 209, pp. 13–22, 2015. View at Publisher · View at Google Scholar · View at Scopus
  5. R. Ross, “Atherosclerosis—an inflammatory disease,” New England Journal of Medicine, vol. 340, pp. 115–126, 1999. View at Publisher · View at Google Scholar · View at Scopus
  6. H. Ait-Oufella, S. Taleb, Z. Mallat, and A. Tedgui, “Recent advances on the role of cytokines in atherosclerosis,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 31, pp. 969–979, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. S. L. Deshmane, S. Kremlev, S. Amini, and B. E. Sawaya, “Monocyte chemoattractant protein-1 (mcp-1): an overview,” Journal of Interferon & Cytokine Research, vol. 29, pp. 313–326, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. G. E. McKellar, D. W. McCarey, N. Sattar, and I. B. McInnes, “Role for tnf in atherosclerosis? Lessons from autoimmune disease,” Nature Reviews. Cardiology, vol. 6, pp. 410–417, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Qamar and D. J. Rader, “Effect of interleukin 1β inhibition in cardiovascular disease,” Current Opinion in Lipidology, vol. 23, pp. 548–553, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. J. Scheller, A. Chalaris, D. Schmidt-Arras, and S. Rose-John, “The pro- and anti-inflammatory properties of the cytokine interleukin-6,” Biochimica et Biophysica Acta (BBA)–Molecular Cell Research, vol. 1813, pp. 878–888, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. D. Kromhout and J. de Goede, “Update on cardiometabolic health effects of ω-3 fatty acids,” Current Opinion in Lipidology, vol. 25, pp. 85–90, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. T. A. Mori, “Omega-3 fatty acids and cardiovascular disease: epidemiology and effects on cardiometabolic risk factors,” Food & Function, vol. 5, pp. 2004–2019, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. T. Nicholson, H. Khademi, and M. H. Moghadasian, “The role of marine n-3 fatty acids in improving cardiovascular health: a review,” Food & Function, vol. 4, pp. 357–365, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. H. Mangge, K. Becker, D. Fuchs, and J. M. Gostner, “Antioxidants, inflammation and cardiovascular disease,” World Journal of Cardiology, vol. 6, pp. 462–477, 2014. View at Publisher · View at Google Scholar
  15. P. Kiuru, M. V. D'Auria, C. D. Muller, P. Tammela, H. Vuorela, and J. Yli-Kauhaluoma, “Exploring marine resources for bioactive compounds,” Planta Medica, vol. 80, pp. 1234–1246, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. H. J. Skaug, H. Gjosæter, T. Haug, U. Lindstrøm, and K. T. Nilssen, “Do minke whales (Balaenoptera acutorostrata) exhibit particular prey preferences?” Journal of Northwest Atlantic Fishery Science, vol. 22, pp. 91–104, 1997. View at Publisher · View at Google Scholar
  17. R. G. Ackman, Marine Biogenic Lipids, Fats and Oils, vol. 2, CRC Press, Boca Raton, FL, USA, 1989.
  18. U. Strandberg, A. Kakela, C. Lydersen et al., “Stratification, composition, and function of marine mammal blubber: the ecology of fatty acids in marine mammals,” Physiological and Biochemical Zoology, vol. 81, pp. 473–485, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. H. Koopman, “Phylogenetic, ecological, and ontogenetic factors influencing the biochemical structure of the blubber of odontocetes,” Marine Biology, vol. 151, pp. 277–291, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. B. Osterud, E. Elvevoll, H. Barstad et al., “Effect of marine oils supplementation on coagulation and cellular activation in whole-blood,” Lipids, vol. 30, pp. 1111–1118, 1995. View at Publisher · View at Google Scholar · View at Scopus
  21. E. Vognild, E. Elvevoll, J. Brox et al., “Effects of dietary marine oils and olive oil on fatty acid composition, platelet membrane fluidity, platelet responses, and serum lipids in healthy humans,” Lipids, vol. 33, pp. 427–436, 1998. View at Publisher · View at Google Scholar · View at Scopus
  22. Orkla Health, Mollers, 2016, May 2017, http://www.mollersomega3.com/product/mollers-tran/.
  23. A. Davalos, C. Gomez-Cordoves, and B. Bartolome, “Extending applicability of the oxygen radical absorbance capacity (orac-fluorescein) assay,” Journal of Agricultural and Food Chemistry, vol. 52, pp. 48–54, 2004. View at Publisher · View at Google Scholar · View at Scopus
  24. I. F. F. Benzie and J. J. Strain, “The ferric reducing ability of plasma (frap) as a measure of “antioxidant power”: the frap assay,” Analytical Biochemistry, vol. 239, pp. 70–76, 1996. View at Publisher · View at Google Scholar · View at Scopus
  25. S. Tsuchiya, M. Yamabe, Y. Yamaguchi, Y. Kobayashi, T. Konno, and K. Tada, “Establishment and characterization of a human acute monocytic leukemia cell line (thp-1),” International Journal of Cancer, vol. 26, pp. 171–176, 1980. View at Publisher · View at Google Scholar
  26. T. Mosmann, “Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays,” Journal of Immunological Methods, vol. 65, pp. 55–63, 1983. View at Publisher · View at Google Scholar · View at Scopus
  27. H. O. Bang, J. Dyerberg, and H. M. Sinclair, “The composition of the eskimo food in north western Greenland,” The American Journal of Clinical Nutrition, vol. 33, pp. 2657–2661, 1980. View at Google Scholar
  28. J. Dyerberg, H. O. Bang, E. Stoffersen, S. Moncada, and J. R. Vane, “Eicosapentaenoic acid and prevention of thrombosis and atherosclerosis?” The Lancet, vol. 312, pp. 117–119, 1978. View at Publisher · View at Google Scholar · View at Scopus
  29. P. Bjerregaard, T. K. Young, and R. A. Hegele, “Low incidence of cardiovascular disease among the inuit—what is the evidence?” Atherosclerosis, vol. 166, pp. 351–357, 2003. View at Publisher · View at Google Scholar · View at Scopus
  30. J. G. Fodor, E. Helis, N. Yazdekhasti, and B. Vohnout, ““Fishing” for the origins of the “eskimos and heart disease” story: facts or wishful thinking?” The Canadian Journal of Cardiology, vol. 30, pp. 864–868, 2014. View at Publisher · View at Google Scholar · View at Scopus
  31. B. L. Halvorsen, M. H. Carlsen, K. M. Phillips et al., “Content of redox-active compounds (ie, antioxidants) in foods consumed in the united states,” The American Journal of Clinical Nutrition, vol. 84, pp. 95–135, 2006. View at Google Scholar
  32. P. Ninfali, G. Mea, S. Giorgini, M. Rocchi, and M. Bacchiocca, “Antioxidant capacity of vegetables, spices and dressings relevant to nutrition,” The British Journal of Nutrition, vol. 93, pp. 257–266, 2005. View at Publisher · View at Google Scholar · View at Scopus
  33. K. Schroder and J. Tschopp, “The inflammasomes,” Cell, vol. 140, pp. 821–832, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. M. Saraiva and A. O'Garra, “The regulation of il-10 production by immune cells,” Nature Reviews. Immunology, vol. 10, pp. 170–181, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. R. Lin, C. Heylbroeck, P. Genin, P. M. Pitha, and J. Hiscott, “Essential role of interferon regulatory factor 3 in direct activation of rantes chemokine transcription,” Molecular and Cellular Biology, vol. 19, pp. 959–966, 1999. View at Publisher · View at Google Scholar
  36. Y.-C. Lu, W.-C. Yeh, and P. S. Ohashi, “Lps/tlr4 signal transduction pathway,” Cytokine, vol. 42, pp. 145–151, 2008. View at Publisher · View at Google Scholar · View at Scopus
  37. E. J. Hennessy, A. E. Parker, and L. A. J. O'Neill, “Targeting toll-like receptors: emerging therapeutics?” Nature Reviews. Drug Discovery, vol. 9, pp. 293–307, 2010. View at Publisher · View at Google Scholar · View at Scopus
  38. Y. S. Kim, H. J. Sung, S. J. Son et al., “Triglyceride (tg) down-regulates expression of mcp-1 and ccr2 in pma-derived thp-1 macrophages,” Genes & Genomics, vol. 35, pp. 125–130, 2013. View at Publisher · View at Google Scholar · View at Scopus